Active: new deal Dec 2025 Verified 5 Nov 2026
Lingotto
New York, NY vehicle of Lingotto, an investment management company owned by Exor that runs several strategies, including the Lingotto Innovation venture strategy.
- Type
- VC firm
- Location
- New York, New York, United States
- Stages
- Growth
- Backs
- Deep tech, Biotech and pharma, B2B software
- Sectors
- AI, Semiconductors, Healthtech and life sciences, Energy, Mobility, Biotech, Generalist
- Fund size / AUM
- Size not stated (Form D, Lingotto Innovation Ventures Fund I, filed 2025-01-30); $107.1M gross private fund assets (Form ADV; private funds: 4, of which venture capital: 0)
- Latest fund or filing
- 30 Jan 2025
- Portfolio mix
- Deep tech 27%; Biotech and pharma 23%; B2B software 15%; Hardware 12%; Climate and energy 12%; Fintech 8%; Medtech and digital health 4% (n=26)
- UK office
- London
- Website
- www.lingotto.com
Contacts on file
For Lingotto, the paid file holds: 3 named decision-makers with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
AirwallexAixtronAmec-incAsmlBot
Sources
- www.sec.gov/Archives/edgar/data/2053261/000205326125000001/
- adviserinfo.sec.gov/firm/summary/328113
- www.lingotto.com
- www.lingotto.com/innovation/team
- www.lingotto.com/innovation/who-we-are
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 44 lists
Growth-stage mobility investors in the US (20)Biotech investors in New York (29)Semiconductor venture capital firms in the US (42)Deep tech investors in New York (42)Growth-stage energy investors in the US (42)Energy investors in New York (43)Growth-stage deep tech investors in the US (43)Growth-stage biotech investors in the US (44)Growth-stage mobility investors (55)Growth-stage investors in New York (57)Semiconductor investors (58)International investors with a UK office (67)Healthtech investors in New York (100)Growth-stage energy investors (102)Growth-stage biotech investors (109)Mobility venture capital firms in the US (120)Growth-stage healthtech investors in the US (121)SaaS investors in New York (138)AI investors in New York (159)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Growth-stage deep tech investors (191)Mobility investors (192)Energy venture capital firms in the US (249)Growth-stage investors in the US (288)Growth-stage AI investors (295)Biotech venture capital firms in the US (297)Growth-stage healthtech investors (316)Deep tech venture capital firms in the US (322)Growth-stage SaaS investors (344)Energy investors (421)Venture capital firms in New York (440)Biotech investors (484)Generalist investors (526)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Deep tech investors (763)SaaS venture capital firms in the US (1,049)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)AI investors (1,576)Venture capital firms in the US (2,975)